Delaney Dennis R - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Delaney Dennis R ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$4,156,701
-5.9%
40,808
-6.8%
2.68%
-0.4%
Q2 2023$4,416,124
+46.9%
43,763
+34.0%
2.69%
+4.9%
Q1 2023$3,005,732
+2.1%
32,671
+0.7%
2.56%
-2.7%
Q4 2022$2,943,955
+18.5%
32,451
-0.8%
2.64%
+10.4%
Q3 2022$2,485,000
+16.6%
32,701
+34.0%
2.39%
-16.5%
Q2 2020$2,132,000
+6.2%
24,412
+0.2%
2.86%
-9.1%
Q1 2020$2,008,000
-12.7%
24,362
+0.3%
3.14%
+6.5%
Q4 2019$2,301,000
+8.2%
24,297
-0.7%
2.95%
+2.0%
Q3 2019$2,126,000
-7.7%
24,472
-3.0%
2.89%
-6.1%
Q2 2019$2,303,000
-4.8%
25,222
+0.2%
3.08%
-5.7%
Q1 2019$2,420,000
+10.5%
25,162
-1.5%
3.27%
-3.6%
Q4 2018$2,191,000
-0.2%
25,540
+0.2%
3.39%
+18.4%
Q3 2018$2,196,000
+19.6%
25,490
+4.8%
2.86%
+8.4%
Q2 2018$1,836,000
-8.7%
24,320
-2.3%
2.64%
-6.6%
Q1 2018$2,011,000
-5.2%
24,885
-1.6%
2.83%
-0.3%
Q4 2017$2,122,000
+37.7%
25,285
+40.9%
2.84%
-5.2%
Q3 2017$1,541,000
+4.6%
17,950
+1.7%
2.99%
+0.6%
Q2 2017$1,473,000
+14.4%
17,650
+1.7%
2.97%
+10.6%
Q1 2017$1,288,000
+2.2%
17,355
+0.2%
2.69%
-0.4%
Q4 2016$1,260,000
-7.8%
17,315
+0.2%
2.70%
-7.0%
Q3 2016$1,366,000
-3.2%
17,285
+1.1%
2.90%
-3.7%
Q2 2016$1,411,000
+14.2%
17,100
+0.2%
3.02%
+12.5%
Q1 2016$1,236,000
-15.6%
17,060
+0.2%
2.68%
-18.1%
Q4 2015$1,464,00017,0303.27%
Other shareholders
NOVARTIS A G shareholders Q3 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders